Trypanosoma cruzi: Susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 36, Issue 2, 2003, Pages 201-209

  Camandaroba, Edson L P ^a   Reis, Eliana A G ^b   Gonçalves, Marilda S ^b   Reis, Mitermayer G ^b   Andrade, Sonia G ^a,c  

^a Ctro Pesq Goncalo Moniz F O C   (Brazil)

^b Laboratorio de Patol e Biol Molec   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Benznidazole; Chagas' disease; Chemotherapy; Clones; Resistance; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHAGAS DISEASE; CLONE; COLOMBIA; CONTROLLED STUDY; INFECTION CONTROL; MOUSE; NONHUMAN; PARASITE SERODIAGNOSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TRYPANOSOMA CRUZI;

ANIMALIA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0038538181     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822003000200002     Document Type: Article

References (30)

1. Andrade ALSS, Zicker F, Oliveira RM, Silva SA, Luquetti A, Travassos LR, Almeida IC, Andrade SS, Andrade JG. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. The Lancet 348:1407-1413,1996.
2. Andrade SG. Trypanosoma cruzi: clonal structure of parasite strains and the importance of principal clones. Memórias do Instituto Oswaldo Cruz 94:185-187, 1999.
3. Andrade SG, Figueira RM. Estudo experimental sobre a ação terapêutica da droga RO7-1051 na infecção por diferentes cepas do T. cruzi. Revista do Instituto de Medicina Tropical de São Paulo 19: 335-341, 1977.
4. Andrade SG, Magalhães JB. Biodemes and Zymodemes of Trypanosoma cruzi: correlations with clinical data and experimental pathology. Revista da Sociedade Brasileira de Medicina Tropical 30: 27-35, 1997.
5. Andrade SG, Magalhães JB, Pontes, AL Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bulletin of the World Health Organization, 63: 721-726, 1985.
6. Andrade SG, Rassi A, Magalhães JB, Ferriolli Filho F, Luquetti AO. Specific chemotherapy of Chagas' disease: a comparison between the response in patients and experimental animals inoculated with the same strains. Transactions of the Royal Society of Tropical Medicine and Hygiene 86: 624-626, 1992.
7. Andrade V, Brodskyn C, Andrade SG. Correlation between isoenzyme patterns and biological behaviour of different strains of Trypanosoma cruzi. Transaction of the Royal Society of Tropical medicine and Hygiene 77: 796-799, 1983.
8. Anonymous. Recommendations from a Satellite Meeting. Memórias do Instituto Oswaldo Cruz 94 (supl 1): 429-432, 1999.
9. Ávila HA, Borges-Pereira J, Thiemann O, De Paiva E, Degrave, W, Morel CM, Simpson L. Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis. Journal of Clinical Microbiology 31:2421-2426, 1993.
10. Ávila HA, Sigman DS, Cohen LM, Millikan RC, Simpson L. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas' disease. Molecular Biochemistry Parasitology 48:211-222, 1991.
11. Britto C, Cardoso MA, Monteiro Vianni CM, Haslocher-Moreno A, Xavier, SS, Oelemann W, Santoro A, Pirmez C, Morel CM, Wincker P. Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation. Parasitology 110: 241-247, 1995.
12. Britto C, Cardoso MA, Ravel C, Santoro AA, Pereira JB, Coura JR, Morel CM, Wincker P. Trypanosoma cruzi parasite detection and strain discrimination in chronic chagasic patients from northeastern Brazil using PCR amplification of kinetoplast DNA and non radioactive hybridization. Experimental Parasitology 81: 462-471,1995.
13. Britto C, Macedo V, Silveira C, Cardoso A, Marques P, Fernandes O. Potencial de aplicação da técnica de PCR na determinação de cura parasitológica em pacientes chagásicos crônicos submetidos a quimioterapia especifica. Revista da Sociedade Brasileira de Medicina Tropical 32 (supl II): 77-78, 1999.
14. Camandaroba ELP, Campos RF, Magalhães JB, Andrade, S.G. Clonal structure of Trypanosoma cruzi Colombian strain (Biodeme Type III): biological, isoenzymic and histopathological analysis of seven isolated clones. Revista da Sociedade Brasileira de Medicina Tropical 34: 151-157, 2001.
15. Campos RMF, Andrade SG. Characterization of subpopulations (clones and subclones) of the 21 SF strain of Trypanosoma cruzi after long lasting maintenance in the laboratory. Memórias do Instituto Oswaldo Cruz 91:795-800, 1996.
16. Campos RMF, Gonçalves MS, Reis EAG, Reis MG, Andrade SG. Comparative analysis by polymerase chain reaction amplified minicircles of kinetoplast DNA of a stable strain of Trypanosoma cruzi from São Felipe, Bahia, its clones and subclones: possibility of predominance of a principal clone in this area. Memórias do Instituto Oswaldo cruz 94: 23-29, 1999.
17. Campos RF, Magalhães JB, Reis EAG, Reis MG, Andrade SG. Sensitivity of the polymerase chain reaction for detection of known aliquots of Trypanosoma cruzi in the blood of mice: an in vitro study. Revista da Sociedade Brasileira de Medicina Tropical 35: 487-490, 2002
18. Dvorak J. Single Cell Isolates of Trypanosoma cruzi: How and Why? Revista da Sociedade Brasileira de Medicina Tropical 18 (supl): 29-38, 1985.
19. Fragata Filho AA, Luquetti AO, Prata A, Rassi A, Gontijo ED, Ferreira HO, Cançado JR, Coura JR, Andrade SG, Macedo V, Amato Neto A, Oliveira Jr W, Brener Z. Ethiological treatment for Chagas' disease. Parasitology Today 13:127-128, 1997.
20. Federici EE, Abelmann WB, Neva FA. Chronic and progressive myocarditis and myositis in C3H mice infected with Trypanosoma cruzi. The American Journal of Tropical Medicine and Hygiene 13: 272-280, 1964.
21. Filardi LS, Brener Z. Nitroimidazole-thiadiazole derivative with curative action in experimental Trypanosoma cruzi infections. Annals of Tropical Medicine and Parasitology 176: 293-287,1982.
22. Marretto JPM, Andrade SG. Biochemical behavior of Trypanosoma cruzi strains isolated from mice submitted to specific chemotherapy. Revista da Sociedade Brasileira de Medicina Tropical 27: 209-215, 1994.
23. Miles MA, Lanham SM, Souza, AA, Póvoa M. Further enzymic characters of Trypanosoma cruzi and their evaluation for strain identification. Transactions of the Royal Society of Tropical Medicine and Hygiene 74: 221-237, 1980.
24. Murta SMF, Romanha AJ. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole. Parasitology 116: 165-171, 1998.
25. Revollo S, Oury B, Laurent J-P, Barnabé C, Quesney V, Carrière V, Nöel S, Tibayrenc M. Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Experimental Parasitology 89: 30-39, 1998.
26. Tibayrenc M, Ward P, Moya A, Ayala FJ. Natural population of Trypanosoma cruzi, the agent of Chagas' disease, have a complex multiclonal structure. Proceedings of the National Academy of Science of Unites States of America 83:115-119, 1986.
27. Tibayrenc M, Brenière SF Trypanosoma cruzi major clones rather than zymodemes. Memórias do Instituto Oswaldo Cruz 83: 249-255, 1988.
28. Warren LG. Metabolism of Schizotrypanum cruzi Chagas. Effect of culture age and substrate concentration on respiratory rate. Journal of Parasitology 46:529-539, 1960.
29. Wincker P, Britto C, Pereira JB, Cardoso A, Oelemann W, Morel CM. Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural area. The American Journal of Tropical Medicine Hygiene 51:771-777, 1994.
30. World Health Organization. Control of Chagas' disease. Report of a WHO Expert Committee. WHO Technical Report Series, Geneva 81-95, 1991.